NA Hydrocephalus Market - Industry Trends and Forecast to 2035

TABLE OF CONTENTS

1 INTRODUCTION 14

• 1.1 OBJECTIVES OF THE STUDY 14
• 1.2 MARKET DEFINITION 14
• 1.3 OVERVIEW OF NORTH AMERICA HYDROCEPHALUS MARKET 14
• 1.4 LIMITATIONS 15
• 1.5 MARKETS COVERED 15

2 MARKET SEGMENTATION 18

• 2.1 MARKETS COVERED 18
• 2.2 GEOGRAPHICAL SCOPE 19
• 2.3 YEARS CONSIDERED FOR THE STUDY 20
• 2.4 CURRENCY AND PRICING 20
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 21
• 2.6 MULTIVARIATE MODELLING 24
• 2.7 TYPE LIFELINE CURVE 24
• 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
• 2.9 DBMR MARKET POSITION GRID 26
• 2.10 VENDOR SHARE ANALYSIS 27
• 2.11 SECONDARY SOURCES 28
• 2.12 ASSUMPTIONS 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 31

5 NORTH AMERICA HYDROCEPHALUS MARKET: REGULATIONS 32

• 5.1 REGULATIONS IN U.S. 32
• 5.2 REGULATIONS IN EUROPE 32
• 5.3 REGULATIONS IN INDIA 32
• 5.4 REGULATIONS IN JAPAN 33
• 5.5 REGULATIONS IN BRAZIL 33

6 MARKET OVERVIEW 34

• 6.1 DRIVERS 36
  • 6.1.1 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS 36
  • 6.1.2 GROWING NUMBER OF NEW-BORNS AFFECTED BY HYDROCEPHALUS 36
  • 6.1.3 INCREASING ADAPTATION OF ADVANCED PROGRAMMABLE VALVES 37
  • 6.1.4 RISING AWARENESS ABOUT HYDROCEPHALUS 37

• 6.2 RESTRAINTS 38
  • 6.2.1 POOR REIMBURSEMENT POLICIES 38
  • 6.2.2 DELETERIOUS COMPLICATIONS WITH HYDROCEPHALUS DEVICES 38
• 6.3 OPPORTUNITIES 39
  • 6.3.1 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES 39
  • 6.3.2 GROWING HEALTHCARE EXPENDITURE 40
  • 6.3.3 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 40
• 6.4 CHALLENGES 41
  • 6.4.1 HIGH PRODUCT RECALL SCENARIO 41
  • 6.4.2 LACK OF ACCESSIBILITY OF HYDROCEPHALUS PRODUCTS 41

7 NORTH AMERICA HYDROCEPHALUS MARKET, BY TYPE 42

• 7.1 OVERVIEW 43
• 7.2 CONGENITAL HYDROCEPHALUS 46
• 7.3 ACQUIRED HYDROCEPHALUS 46
• 7.4 NORMAL-PRESSURE HYDROCEPHALUS 47
• 7.5 EX-VACUO HYDROCEPHALUS 47

8 NORTH AMERICA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT 48

• 8.1 OVERVIEW 49
• 8.2 DIAGNOSTICS 52
  • 8.2.1 MAGNETIC RESONANCE IMAGING (MRI) 52
  • 8.2.2 CT SCAN - HEAD 52
  • 8.2.3 HEAD ULTRASOUND 53
• 8.3 TREATMENT 53
  • 8.3.1 SURGERY - SHUNT INSERTION, BY PRODUCT TYPE 54
    • 8.3.1.1 HYDROCEPHALUS VALVES 54
    • 8.3.1.2 HYDROCEPHALUS CATHETERS 54
      • 8.3.1.2.1 ADJUSTABLE PRESSURE VALVES 54
      • 8.3.1.2.2 FIX PRESSURE VALVES 55
  • 8.3.2 SURGERY - SHUNT INSERTION, BY AGE GROUP 55
    • 8.3.2.1 PEDIATRIC 55
    • 8.3.2.2 ADULT 55
  • 8.3.3 VENTRICULOSTOMY 55
  • 8.3.4 MEDICATION 55
  • 8.3.5 TREATMENT, BY AGE GROUP 56
  • 8.3.6 INFANTS 56
  • 8.3.7 CHILDREN 56
  • 8.3.8 ADULTS 56

9 NORTH AMERICA HYDROCEPHALUS MARKET, BY END USERS 57

• 9.1 OVERVIEW 58
• 9.2 HOSPITALS 61
• 9.3 CLINICS 61
• 9.4 DIAGNOSTIC CENTERS 62
• 9.5 ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS 62
  • 9.5.1 HOSPITALS 63
  • 9.5.2 AMBULATORY AND SURGICAL CENTERS 63
  • 9.5.3 HOSPITALS 63
  • 9.5.4 CLINICS 63
  • 9.5.5 DIAGNOSTIC CENTER 64
  • 9.5.6 SURGICAL CENTERS 64
  • 9.5.7 AMBULATORY SURGICAL CENTERS 64
  • 9.5.8 OTHERS 64

10 NORTH AMERICA HYDROCEPHALUS MARKET, BY REGION 65

• 10.1 OVERVIEW 66
• 10.2 NORTH AMERICA 69
  • 10.2.1 U.S. 73
  • 10.2.2 CANADA 77
  • 10.2.3 MEXICO 81

11 NORTH AMERICA HYDROCEPHALUS MARKET, COMPANY LANDSCAPE 85

• 11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 85

12 SWOT ANALYSIS 86

13 COMPANY PROFILE 87

• 13.1 MEDTRONIC 87
  • 13.1.1 COMPANY SNAPSHOT 87
  • 13.1.2 REVENUE ANALYSIS 87
  • 13.1.3 COMPANY SHARE ANALYSIS 88
  • 13.1.4 PRODUCT PORTFOLIO 88
  • 13.1.5 RECENT DEVELOPMENTS 88
• 13.2 AESCULAP, INC. - A B. BRAUN COMPANY 89
  • 13.2.1 COMPANY SNAPSHOT 89
  • 13.2.2 COMPANY SHARE ANALYSIS 89
  • 13.2.3 PRODUCT PORTFOLIO 90
  • 13.2.4 RECENT DEVELOPMENT 90

• 13.3 INTEGRA LIFESCIENCES 91
  • 13.3.1 COMPANY SNAPSHOT 91
  • 13.3.2 REVENUE ANALYSIS 91
  • 13.3.3 COMPANY SHARE ANALYSIS 92
  • 13.3.4 PRODUCT PORTFOLIO 92
  • 13.3.5 RECENT DEVELOPMENT 93
• 13.4 SPIEGELBERG GMBH & CO. KG 94
  • 13.4.1 COMPANY SNAPSHOT 94
  • 13.4.2 COMPANY SHARE ANALYSIS 94
  • 13.4.3 PRODUCT PORTFOLIO 95
  • 13.4.4 RECENT DEVELOPMENT 95
• 13.5 BICAKCILAR 96
  • 13.5.1 COMPANY SNAPSHOT 96
  • 13.5.2 COMPANY SHARE ANALYSIS 96
  • 13.5.3 PRODUCT PORTFOLIO 97
  • 13.5.4 RECENT DEVELOPMENTS 97
• 13.6 ANUNCIA INC 98
  • 13.6.1 COMPANY SNAPSHOT 98
  • 13.6.2 PRODUCT PORTFOLIO 98
  • 13.6.3 RECENT DEVELOPMENT 98
• 13.7 CHRISTOPH MIETHKE GMBH & CO. KG 99
  • 13.7.1 COMPANY SNAPSHOT 99
  • 13.7.2 PRODUCT PORTFOLIO 99
  • 13.7.3 RECENT DEVELOPMENT 100
• 13.8 DESU MEDICAL 101
  • 13.8.1 COMPANY SNAPSHOT 101
  • 13.8.2 PRODUCT PORTFOLIO 101
  • 13.8.3 RECENT DEVELOPMENT 101
• 13.9 G.SURGIWEAR LTD 102
  • 13.9.1 COMPANY SNAPSHOT 102
  • 13.9.2 PRODUCT PORTFOLIO 102
  • 13.9.3 RECENT DEVELOPMENT 102
• 13.10 HPBIO 103
  • 13.10.1 COMPANY SNAPSHOT 103
  • 13.10.2 PRODUCT PORTFOLIO 103
  • 13.10.3 RECENT DEVELOPMENT 103

• 13.11 KANEKA MEDIX CORP 104
  • 13.11.1 COMPANY SNAPSHOT 104
  • 13.11.2 REVENUE ANALYSIS 104
  • 13.11.3 PRODUCT PORTFOLIO 106
  • 13.11.4 RECENT DEVELOPMENTS 106
• 13.12 KARL STORZ SE & CO. KG 107
  • 13.12.1 COMPANY SNAPSHOT 107
  • 13.12.2 PRODUCT PORTFOLIO 107
  • 13.12.3 RECENT DEVELOPMENT 107
• 13.13 MOLLER MEDICAL GMBH 108
  • 13.13.1 COMPANY SNAPSHOT 108
  • 13.13.2 PRODUCT PORTFOLIO 108
  • 13.13.3 RECENT DEVELOPMENT 108
• 13.14 NATUS MEDICAL INCORPORATED 109
  • 13.14.1 COMPANY SNAPSHOT 109
  • 13.14.2 PRODUCT PORTFOLIO 109
  • 13.14.3 RECENT DEVELOPMENTS 110
• 13.15 SOPHYSA 111
  • 13.15.1 COMPANY SNAPSHOT 111
  • 13.15.2 PRODUCT PORTFOLIO 111
  • 13.15.3 RECENT DEVELOPMENTS 112

14 QUESTIONNAIRE 113

15 RELATED REPORTS 116

LIST OF TABLES

• TABLE 1 NORTH AMERICA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 45
• TABLE 2 NORTH AMERICA CONGENITAL HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 46
• TABLE 3 NORTH AMERICA ACQUIRED HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 46
• TABLE 4 NORTH AMERICA NORMAL-PRESSURE HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 47
• TABLE 5 NORTH AMERICA EX-VACUO HYDROCEPHALUS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 47
• TABLE 6 NORTH AMERICA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 51
• TABLE 7 NORTH AMERICA DIAGNOSTIC IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD MILLION) 52
• TABLE 8 NORTH AMERICA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 52
• TABLE 9 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY REGION, 2019-2028 (USD MILLION) 53
• TABLE 10 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 53
• TABLE 11 NORTH AMERICA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 54
• TABLE 12 NORTH AMERICA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 54
• TABLE 13 NORTH AMERICA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 55
• TABLE 14 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 56
• TABLE 15 NORTH AMERICA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 60
• TABLE 16 NORTH AMERICA HOSPITALS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
• TABLE 17 NORTH AMERICA CLINICS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
• TABLE 18 NORTH AMERICA DIAGNOSTIC CENTERS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 62
• TABLE 19 NORTH AMERICA ACADEMIC INSTITUTIONS AND RESEARCH ORGANIZATIONS IN HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 62
• TABLE 20 NORTH AMERICA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 63
• TABLE 21 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 63
• TABLE 22 NORTH AMERICA HYDROCEPHALUS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 68
• TABLE 23 NORTH AMERICA HYDROCEPHALUS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 69
• TABLE 24 NORTH AMERICA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 69
• TABLE 25 NORTH AMERICA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 69
• TABLE 26 NORTH AMERICA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 70
• TABLE 27 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 70
• TABLE 28 NORTH AMERICA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 70
• TABLE 29 NORTH AMERICA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 71
• TABLE 30 NORTH AMERICA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 71
• TABLE 31 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 71
• TABLE 32 NORTH AMERICA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 72
• TABLE 33 NORTH AMERICA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 72
• TABLE 34 NORTH AMERICA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 72
• TABLE 35 U.S. HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 73
• TABLE 36 U.S. HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 73
• TABLE 37 U.S. DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 73
• TABLE 38 U.S. TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 74
• TABLE 39 U.S. SURGERY -SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 74
• TABLE 40 U.S. HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 74
• TABLE 41 U.S. SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 75
• TABLE 42 U.S. TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 75
• TABLE 43 U.S. HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 75
• TABLE 44 U.S. SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 76
• TABLE 45 U.S. TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 76
• TABLE 46 CANADA HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 77
• TABLE 47 CANADA HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 77
• TABLE 48 CANADA DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 77
• TABLE 49 CANADA TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 78
• TABLE 50 CANADA HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 78
• TABLE 51 CANADA HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 78
• TABLE 52 CANADA SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 79
• TABLE 53 CANADA TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 79
• TABLE 54 CANADA HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 79
• TABLE 55 CANADA SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 80
• TABLE 56 CANADA TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 80
• TABLE 57 MEXICO HYDROCEPHALUS MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 81
• TABLE 58 MEXICO HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 81
• TABLE 59 MEXICO DIAGNOSTICS IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 81
• TABLE 60 MEXICO TREATMENT IN HYDROCEPHALUS MARKET, BY DIAGNOSTICS & TREATMENT, 2022-2031 (USD THOUSAND) 82
• TABLE 61 MEXICO HYDROCEPHALUS SHUNTS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 82
• TABLE 62 MEXICO HYDROCEPHALUS CATHETERS IN HYDROCEPHALUS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND) 82
• TABLE 63 MEXICO SURGERY - SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 83
• TABLE 64 MEXICO TREATMENT IN HYDROCEPHALUS MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 83
• TABLE 65 MEXICO HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 83
• TABLE 66 MEXICO SURGERY-SHUNT INSERTION IN HYDROCEPHALUS MARKET, BY END USERS, 2022-2031 (USD THOUSAND) 84
• TABLE 67 MEXICO TREATMENT IN HYDROCEPHALUS MARKET , BY END USERS, 2022-2031 (USD THOUSAND) 84

LIST OF FIGURES

• FIGURE 1 NORTH AMERICA HYDROCEPHALUS MARKET: SEGMENTATION 18
• FIGURE 2 NORTH AMERICA HYDROCEPHALUS MARKET: DATA TRIANGULATION 21
• FIGURE 3 NORTH AMERICA HYDROCEPHALUS MARKET: DROC ANALYSIS 22
• FIGURE 4 NORTH AMERICA HYDROCEPHALUS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 23
• FIGURE 5 NORTH AMERICA HYDROCEPHALUS MARKET: COMPANY RESEARCH ANALYSIS 23
• FIGURE 6 NORTH AMERICA HYDROCEPHALUS MARKET: INTERVIEW DEMOGRAPHICS 25
• FIGURE 7 NORTH AMERICA HYDROCEPHALUS MARKET: DBMR MARKET POSITION GRID 26
• FIGURE 8 NORTH AMERICA HYDROCEPHALUS MARKET: VENDOR SHARE ANALYSIS 27
• FIGURE 9 NORTH AMERICA HYDROCEPHALUS MARKET: SEGMENTATION 30
• FIGURE 10 INCREASING INCIDENCE OF NEUROLOGICAL CONDITIONS IS EXPECTED TO DRIVE THE NORTH AMERICA HYDROCEPHALUS MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 31
• FIGURE 11 CONGENITAL HYDROCEPHALUS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA HYDROCEPHALUS MARKET IN 2024 & 2031 31
• FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA HYDROCEPHALUS MARKET 35
• FIGURE 13 NORTH AMERICA HYDROCEPHALUS MARKET: BY TYPE, 2023 43
• FIGURE 14 NORTH AMERICA HYDROCEPHALUS MARKET: BY TYPE, 2024-2031 (USD THOUSAND) 44
• FIGURE 15 NORTH AMERICA HYDROCEPHALUS MARKET: BY TYPE, CAGR (2024-2031) 44
• FIGURE 16 NORTH AMERICA HYDROCEPHALUS MARKET: BY TYPE, LIFELINE CURVE 45
• FIGURE 17 NORTH AMERICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2023 49
• FIGURE 18 NORTH AMERICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, 2024-2031 (USD THOUSAND) 50
• FIGURE 19 NORTH AMERICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, CAGR (2024-2031) 50
• FIGURE 20 NORTH AMERICA HYDROCEPHALUS MARKET: BY DIAGNOSTICS & TREATMENT, LIFELINE CURVE 51
• FIGURE 21 NORTH AMERICA HYDROCEPHALUS MARKET: BY END USERS, 2023 58
• FIGURE 22 NORTH AMERICA HYDROCEPHALUS MARKET: BY END USERS, 2024-2031 (USD THOUSAND) 59
• FIGURE 23 NORTH AMERICA HYDROCEPHALUS MARKET: BY END USERS, CAGR (2024-2031) 59
• FIGURE 24 NORTH AMERICA HYDROCEPHALUS MARKET: BY END USERS, LIFELINE CURVE 60
• FIGURE 25 NORTH AMERICA HYDROCEPHALUS MARKET: SNAPSHOT (2023) 67
• FIGURE 26 NORTH AMERICA HYDROCEPHALUS MARKET: COMPANY SHARE 2023 (%) 85